Sponsor pipeline

Beat AML, LLC clinical trial pipeline

Get alerts when Beat AML, LLC's trials change

1 active trials 1 recruiting 1 Phase 3 2 disease areas 7 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-09-05

What changed in the last 30 days

2026-09-04
Primary completion pushed: 2028-12 → 2032-12
Primary endpoint(s) modified
Phase changed: Phase 1/2 → Phase 2/3
Interventions modified
Trial sites expanded: 19 → 31 locations
Completion pushed: 2028-12 → 2032-12
Trial arms changed: 18 → 23
NCT03013998 Study of Biomarker-Based Treatment of Acute Myeloid Leukemia · Phase 2/3

Active trials by phase

Phase 2/3
1

Active trials

NCT IDTitleConditionStatusUpdated
Phase 2/3
NCT03013998 Study of Biomarker-Based Treatment of Acute Myeloid Leukemia Previously Untreated Relapsed Refractory Acute Myeloid Leukemia Recruiting 2026-09-03

Disease areas by active trials

Acute Myeloid Leukemia (AML) (1) · Leukemia (1)

Get alerts when Beat AML, LLC's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free